Ofloxacine Viatris

Ofloxacin, the active ingredient in Ofloxacine Viatris, is a fluoroquinolone antibiotic presented as a tablet for oral use. It treats a variety of bacterial infections in adults and children when prescribed by a healthcare professional.

GNH USA supplies Ofloxacine Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ofloxacine Viatris is a broad‑spectrum fluoroquinolone indicated for bacterial infections affecting several organ systems: - Urinary tract infections: helps eradicate common uropathogens and relieve symptoms. - Respiratory tract infections: effective against typical community‑acquired pathogens causing bronchitis and sinusitis. - Skin and soft‑tissue infections: combats susceptible Staphylococcus aureus and Streptococcus species to promote healing.

Ofloxacine Viatris may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild stomach upset reported by some patients. - Diarrhea: loose stools occurring during treatment. - Headache: transient head pain without neurological signs. - Dizziness: occasional light‑headed sensation. - Rash: mild skin redness or itching. - Photosensitivity: increased skin sensitivity to sunlight.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or rupture, especially in the Achilles. - QT interval prolongation: heart rhythm changes detectable on ECG. - Severe allergic reactions: anaphylaxis, angioedema or bronchospasm. - Peripheral neuropathy: numbness or tingling in extremities. - Hepatotoxicity: elevated liver enzymes or jaundice. - Clostridioides difficile infection: severe colitis following antibiotic use.

Before prescribing Ofloxacine Viatris, clinicians should consider several safety aspects: - Pregnancy: avoid use unless clearly needed, as fetal risk cannot be excluded. - Breastfeeding: assess risk versus benefit; small amounts may pass into milk. - Tendon disorders: discontinue if tendon pain, swelling or rupture occurs. - Cardiac risk: monitor patients with known QT prolongation or electrolyte imbalance. - Renal impairment: adjust dosing in severe kidney dysfunction. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Ofloxacine Viatris can interact with several medicines, altering efficacy or safety:

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce ofloxacin absorption. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of central nervous system stimulation. - Warfarin: may enhance anticoagulant effect and raise bleeding risk.

Moderate Interactions (Monitor Closely): - Corticosteroids: combined use may raise tendon‑rupture risk. - Diabetic agents: ofloxacin may affect blood glucose control. - Theophylline: plasma concentrations can rise, requiring dose adjustment.